We provide the following in light of the recent enquiries to SROS regarding the Organisations
molecular and drug testing capabilities.
The Scientific Research Organisation of Samoa has over the years increased its molecular and
drug testing capabilities due to requests from the Law and Justice, Agriculture and Health
Sectors. At present, SROS has qualified and certified scientists who have been trained in the
field of molecular diagnostics and drug analysis.
Since the COVID-19 pandemic, SROS has acquired several RT-qPCR equipment with support
from UNDP, UNICEF, FAO, IAEA and our Government. RT-qPCR is a World Health

Organisation recommended nucleic acid-base technique for molecular diagnostics of COVID-
19. This equipment utilizes a molecular technique to amplify a target specific genetic sequence

of interest. RT-qPCR can amplify and detect a single copy of the specific genomic sequence. This
equipment allows SROS scientists to determine the presence or absence of COVID-19 and can
also provide preliminary determination of the variant. To determine which COVID-19 variant is
in a sample with confidence, SROS is acquiring further consumables that can be used with our
present equipment. This will remove the need to send samples to overseas countries for
confirmation of the virus variants.
Given overseas travel requirements at present require a COVID-19 test results, SROS has
utilized its resources for about two years now to accommodate those in need of its services. The
traveler’s COVID-19 swabs collected by local medical clinics are delivered to SROS for analyses.
To date, SROS has tested more than 500 outgoing travelers.
The Ministry of Health (MoH) is also well equipped to carry out COVID-19 tests and has
maintained the testing of travelers at our borders and people of concern. MoH has done an
excellent job given the high pressure conditions they are working under. We applaud their
excellent work. SROS molecular diagnostic services are available to support the MoH when the
need arises.
SROS is also planning to acquire equipment for genomic sequencing. Genomic sequencing is
integral in any COVID-19 response as new variants are continuously emerging. Genomic data
has guided countries to make quick and informed public health decisions since the start of the
pandemic, and Samoa would likewise benefit from having timely access to the genomic
information of COVID-19 cases presenting in Samoa. Most mutations don’t significantly alter a
virus’ behavior, but some can be concerning. Genomic sequencing involves decoding the genetic
material of a virus to identify the mutations and determine what effect they might have on the
virus’ pathogenicity. This process is done in a laboratory and can be analyzed within 24 hours.
If there are any further enquiries, please do not hesitate to contact our office directly
SROS Management